Here is the full comprehensive reference document on gastric tumour radiology, synthesized from Grainger & Allison's Diagnostic Radiology, Yamada's Gastroenterology, and current classification systems:
Gastric Tumours: Complete Radiology Reference
1. NORMAL PERIGASTRIC ANATOMY
Stomach on Imaging
On CT (water distension protocol - 6-8 cups before scan), normal gastric wall = <5 mm when well distended. On barium double-contrast studies:
- Areae gastricae: fine reticular network of mucosal tufts separated by sulci (2-3 mm antrum, 3-5 mm body/fundus) - seen in ~70% patients
- Gastric rugae: smooth folds 3-5 mm thick, parallel to long axis, comprise mucosa + submucosa
Perigastric Ligaments & Stomach Bed
| Ligament | Contents | Connections |
|---|
| Gastrohepatic (lesser omentum) | Left gastric vessels, aberrant left hepatic artery | Lesser curvature → porta hepatis |
| Gastrocolic | Right/left gastroepiploic vessels | Greater curvature → transverse colon |
| Gastrosplenic | Short gastric vessels, left gastroepiploic | Greater curvature → splenic hilum |
| Gastrophrenic | Short gastric vessels (superior) | Fundus → diaphragm |
Stomach Bed (posterior wall relations on CT - critical for T4b staging):
- Pancreatic body/tail (most important)
- Left kidney and left adrenal
- Splenic vessels and spleen
- Transverse mesocolon
- Left crus of diaphragm
Lymph Node Stations (Japanese Gastric Cancer Association)
| Station | Location | D-level |
|---|
| 1 | Right paracardial | D1 |
| 2 | Left paracardial | D1 |
| 3 | Lesser curvature (left gastric territory) | D1 |
| 4sa/4sb/4d | Greater curvature (short gastric / gastroepiploic) | D1 |
| 5 | Suprapyloric | D1 |
| 6 | Infrapyloric | D1 |
| 7 | Along left gastric artery | D2 |
| 8a | Along common hepatic artery (anterior) | D2 |
| 9 | Along celiac axis | D2 |
| 10 | Splenic hilum | D2 |
| 11p/11d | Along proximal/distal splenic artery | D2 |
| 12a | Hepatoduodenal ligament | D2 |
| 13-16 | Retropancreatic, SMA, para-aortic | Distant (M1) |
D1 = stations 1-6 | D2 = stations 1-11 (standard curative) | Para-aortic = M1 disease
CT criterion for abnormal node: >8 mm short-axis diameter in perigastric region. Rim enhancement or central necrosis = malignant regardless of size.
2. GASTRIC CARCINOMA
90-95% of all malignant gastric tumours. Peak age 50-70 years. Distributed: ~one-third each in antrum, body, fundus-cardia; 10% diffusely infiltrative. Risk factors: H. pylori, chronic atrophic gastritis, autoimmune gastritis, polyposis syndromes.
Lauren Classification:
- Intestinal type: gland-forming, H. pylori-associated, better prognosis, FDG-avid
- Diffuse type (signet ring): no gland formation, infiltrates wall, linitis plastica, FDG-negative
- Mixed
3. EARLY GASTRIC CANCER (EGC)
Definition: Carcinoma confined to mucosa (T1a) or submucosa (T1b), regardless of lymph node status. Originates from the Japanese screening program.
Japanese Morphological Classification:
| Type | Morphology |
|---|
| I | Polypoid, protrudes >5 mm into lumen |
| IIa | Superficial elevated, <5 mm |
| IIb | Flat |
| IIc | Superficial depressed (most common; highest risk of LN mets) |
| III | Excavated/ulcerated |
| IV | Lateral spreading |
CT Features (MDCT):
- Focal thickening of the inner mucosal layer only
- Abnormal focal mucosal hyperenhancement on arterial phase
- Preservation of outer hypodense stripe (submucosa) - the key T1 sign
- Clear perigastric fat plane
- T1 lesions without thickening are extremely difficult to detect; surface-shaded display or virtual gastroscopy (VG) may demonstrate them
- EUS is superior to CT for T1/T2 distinction
4. ADVANCED GASTRIC CANCER (AGC)
Definition: Invades muscularis propria (T2) or beyond. Most common presentation in Western countries.
Borrmann Classification:
| Type | Description | Prognosis |
|---|
| I | Polypoid, sharply demarcated | Best |
| II | Ulcerated, sharply demarcated | Good |
| III | Ulcerated, infiltrating margins | Intermediate |
| IV | Diffusely infiltrating (linitis plastica) | Worst |
| V | Unclassifiable | |
CT Features:
- Polypoid: irregular mass; shelf sign (acute angle to wall = mucosal origin)
- Ulcerative: malignant ulcer sits WITHIN the gastric wall/mass (not projecting beyond wall); irregular nodular fold convergence (clubbed, amputated); no Hampton's line
- Linitis plastica (scirrhous/Borrmann IV): diffuse thickening, loss of rugae, rigid non-distensible "leather bottle" stomach, perigastric fat stranding
- Antral carcinoma: may cause gastric outlet obstruction
Benign vs Malignant Ulcer:
| Feature | Benign | Malignant |
|---|
| Position | Projects beyond wall outline | Within wall/mass |
| Margin | Smooth halo | Irregular, nodular |
| Fold convergence | Smooth, tapers | Clubbed, nodular, amputated |
| Hampton's line | Present | Absent |
| Carman meniscus sign | Absent | Present (en face) |
| Adjacent mass | None | Present |
| Distensibility | Normal | Rigid |
5. TNM STAGING (AJCC 8th Edition)
T Stage:
| T | Definition |
|---|
| T1a | Lamina propria / muscularis mucosae |
| T1b | Submucosa |
| T2 | Muscularis propria |
| T3 | Subserosa (no serosal penetration) |
| T4a | Serosa (visceral peritoneum) penetrated |
| T4b | Adjacent organs (pancreas, spleen, colon, liver, diaphragm, kidney, adrenal, small bowel, retroperitoneum) |
N Stage:
| N | Regional Nodes |
|---|
| N0 | None |
| N1 | 1-2 nodes |
| N2 | 3-6 nodes |
| N3a | 7-15 nodes |
| N3b | ≥16 nodes |
M Stage:
- M1 = any distant mets (liver first, then peritoneum, lung, adrenal, bone, Krukenberg ovary)
- Positive peritoneal cytology = M1
- Para-aortic nodal disease = M1
Imaging by Stage:
| Modality | Optimal Use | Notes |
|---|
| EUS | T1-T2 distinction | 65-92% accuracy; poor for T3/T4 |
| MDCT (triphasic) | Overall staging (T3+, N, M) | Gold standard; water oral contrast |
| MRI | Liver mets, equivocal CT | Limited T1/T2 discrimination |
| FDG-PET/CT | Distant M staging, N3, response | Unreliable for N1/N2 (too close to primary) |
| Diagnostic laparoscopy | Peritoneal mets | Highest sensitivity for peritoneal disease |
CT Protocol: Oral water (negative contrast), IV contrast arterial + portal venous phases, MPR coronal and sagittal, adequate gastric distension required.
Perigastric Fat Plane Assessment:
- T3: haziness/stranding in fat; outer wall irregular
- T4a: serosal nodularity; loss of outer definition
- T4b: loss of fat plane + adjacent organ deformity
6. PET-NEGATIVE TUMOURS & PATHOLOGY
Gastric Carcinoma Subtypes That Are PET-Negative:
- Mucinous adenocarcinoma - mucin lakes with sparse metabolically active cells
- Signet ring cell carcinoma - poorly differentiated, discohesive, low metabolic density
- Poorly differentiated adenocarcinoma
- Diffuse type (Lauren) overall
- Low-grade MALToma
PET Limitations in Gastric Cancer (from Grainger & Allison):
- Intense variable physiological uptake in normal gastric wall (masks small primaries)
- Poor spatial resolution for N1/N2 (perigastric nodes too close to primary)
- Better for N3 distant nodes (high specificity)
- Metabolic response in FDG-avid tumours identifies therapy responders earlier than morphology
Other PET-Negative Gastric Pathologies:
| Entity | Reason | Alternative |
|---|
| Well-differentiated NET/Carcinoid (G1) | Low proliferation index | Ga-68 DOTATATE PET |
| GIST (low-risk, small) | Low mitotic rate | CT (Choi criteria) |
| Lipoma | No metabolic activity | CT (fat density) |
| Leiomyoma | Benign | CT/MRI morphology |
| Ectopic pancreatic tissue | Normal tissue | EUS + CT morphology |
| Mucinous peritoneal mets | Acellular mucin pools | CT/MRI |
| Low-grade MALToma | Indolent | CT, endoscopy |
| Lobular breast mets | Signet-ring-like, low avidity | Clinical history |
7. MESENCHYMAL TUMOURS
GIST (Gastrointestinal Stromal Tumour)
Pathognomonic marker: CD117 (c-KIT) positive; DOG-1 positive; CD34 positive (70%). Arises from interstitial cells of Cajal.
Most common non-epithelial GI tumour. Location: stomach 60-70%, small bowel 20-30%.
CT (method of choice):
- Submucosal/extraluminal (exophytic) growth pattern
- Small tumours: homogeneous, well-defined, uniform enhancement
- Large/malignant tumours: heterogeneous, central necrosis/haemorrhage/cystic change
- Ulceration of overlying mucosa ("rose-thorn" or endoluminal niche)
- No lymph node metastasis (key feature - distinguishes from carcinoma and lymphoma)
- Liver mets (haematogenous) and peritoneal spread - NO lymph node spread
- Pseudo-progression on imatinib (tumours become cystic/hypoattenuating) - use Choi criteria (density decrease >15% OR size >10%), not RECIST
Risk Stratification (Miettinen):
| Risk | Size | Mitoses (/50 HPF) | Gastric |
|---|
| Very low | <2 cm | <5 | Yes |
| Low | 2-5 cm | <5 | Yes |
| Intermediate | <5 cm, 6-10 mit | OR 5-10 cm, <5 mit | Yes |
| High | >10 cm any; OR >5 cm >5 mit; OR >10 mit any size | Yes | |
Malignant GIST features on CT: size >5 cm, irregular margins, heterogeneous enhancement, central necrosis, adjacent structure infiltration, liver/peritoneal mets.
Gastric Lipoma
- Pathognomonic: Fat-density mass (HU -80 to -120) with thin capsule
- Most common in antrum (submucosal location)
- MRI: T1 bright, T2 bright, suppresses on fat saturation
- Compressible on fluoroscopy
- Benign; no malignant potential
Leiomyoma
- Smooth muscle tumour from muscularis propria or muscularis mucosae
- Most common at cardia / gastroesophageal junction
- CT: homogeneous, well-defined, mild-moderate enhancement; calcification ~10%
- CD117 negative, desmin/SMA positive - unlike GIST
- Smaller, no exophytic growth tendency, no necrosis
Glomus Tumour
- Extremely rare benign vascular tumour of modified smooth muscle (glomus body cells)
- Occurs almost exclusively in antrum (submucosal)
- CT pathognomonic feature: Intensely hypervascular, homogeneous, arterial phase enhancement (equal to or exceeding aorta)
- MRI: T2 very high signal, avid gadolinium enhancement
- Key differentiator from carcinoid: even more intensely vascular, more homogeneous
Paraganglioma
- Extra-adrenal chromaffin cell tumour; gastric location extremely rare
- MRI pathognomonic: "Salt and pepper" appearance on T2 (flow voids = pepper; haemorrhagic foci = salt)
- CT: hypervascular mass, intense arterial enhancement
- Ga-68 DOTATATE PET positive
- Malignancy only determined by metastatic spread, not histology
Schwannoma
- Rare; most common benign gastric neurogenic tumour
- CT: well-defined homogeneous submucosal mass; peripheral lymph node cuff is characteristic
- S100 positive, CD117 negative, CD34 negative
8. GASTRIC LYMPHOMA
The stomach is the most common site of primary GI lymphoma (>70%). Almost exclusively NHL.
Subtypes:
- Low-grade MALToma: H. pylori-associated (CagA protein), indolent; may regress with H. pylori eradication alone
- DLBCL: High-grade; may arise de novo or from MALToma transformation; aggressive
Imaging Features:
- CT: Diffuse or segmental mural thickening (often >2 cm), preserved perigastric fat planes (key differentiator)
- Homogeneous enhancement; bulky regional adenopathy
- Can cross the pylorus (unlike carcinoma which tends to respect it)
- Multiple submucosal nodules, ulcerations, polypoid masses on barium
Lymphoma vs Carcinoma on CT:
| Feature | Lymphoma | Carcinoma |
|---|
| Fat planes | Preserved | Obliterated (advanced) |
| Enhancement | Homogeneous | Heterogeneous |
| Wall thickness | Often >2 cm | Variable |
| Pylorus crossing | Yes | No |
| Nodal pattern | Bulky, homogeneous | Heterogeneous, smaller |
| Peristalsis | Preserved longer | Rigid early |
Dawson Criteria (Primary GI Lymphoma):
- No peripheral lymphadenopathy at presentation
- No mediastinal lymphadenopathy
- Normal WBC and differential on peripheral blood
- Predominantly bowel involvement with regional nodes only
- No hepatic or splenic involvement (except by direct extension)
Lugano Classification (GI Lymphoma Staging):
| Stage | Extent |
|---|
| I | Confined to GI tract (single or multiple non-contiguous) |
| II1 | Extending into abdomen with local node involvement |
| II2 | Extending with distant abdominal nodes |
| IIE | Serosa penetrated; adjacent organ involved |
| IV | Disseminated extranodal or supradiaphragmatic nodal involvement |
Lugano 5-Point Deauville Scale (PET Response):
| Score | FDG uptake | Interpretation |
|---|
| 1 | No uptake | Complete metabolic response |
| 2 | ≤ mediastinum | Complete metabolic response |
| 3 | > mediastinum, ≤ liver | Adequate response (context-dependent) |
| 4 | Moderately > liver | Incomplete response |
| 5 | Markedly > liver OR new lesions | Incomplete/progressive |
FDG-PET/CT is the gold standard for staging FDG-avid histologies (DLBCL, Hodgkin's). MALToma is variably avid - stage with CT.
9. CARCINOID / NEUROENDOCRINE TUMOUR (NET)
| Type | Association | Features |
|---|
| Type 1 | Chronic atrophic gastritis / pernicious anaemia | Multiple small (<1 cm), ECL cell, low malignant potential |
| Type 2 | ZES / MEN-1 | Multiple, ECL cell, moderate risk |
| Type 3 | Sporadic | Solitary, large, aggressive, liver mets common |
- CT: small hypervascular submucosal nodules (Types 1/2); large single mass (Type 3)
- Ga-68 DOTATATE PET is the modality of choice - FDG negative (G1/G2)
- G3 neuroendocrine carcinoma (NEC): FDG-positive
10. CARCINOMA MIMICS
Ménétrier's Disease
- Foveolar cell hyperplasia, protein-losing enteropathy
- Barium/CT: Massively enlarged, bizarre lobulated folds - proximal stomach and greater curvature, classic antral sparing (antrum involved up to 50%)
- Folds remain pliable - key differentiator (carcinoma = rigid, aperistaltic)
- Increased small bowel fluid (protein-losing)
- Fibrosing variant mimics linitis plastica
Zollinger-Ellison Syndrome (ZES)
- Gastrinomas (75% pancreas, 15% duodenum); 50% malignant with liver mets
- Gastric imaging: Thickened folds + excess gastric secretions, multiple peptic ulcers (distal duodenum/jejunum - 4th part)
- CT: hypervascular pancreatic/duodenal mass; gastrinoma triangle
- Associated with MEN-1
- Ga-68 DOTATATE PET / Octreotide scan for tumour detection
Eosinophilic Gastritis
- Diffuse eosinophil infiltration in atopic/asthmatic patients
- CT: diffuse wall thickening, antral narrowing and rigidity, mucosal nodularity
- Eosinophilic ascites (serosal involvement)
- Peripheral eosinophilia
Amyloidosis
- Submucosal amyloid deposition
- CT: diffuse wall thickening, rigidity - mimics linitis plastica
- Non-specific; diagnosis by biopsy (Congo red staining, apple-green birefringence)
Corrosive Gastritis
- Acid ingestion: necrosis → fibrosis
- CT/barium late: severely deformed, contracted stomach ("tobacco pouch"), luminal narrowing down to duodenal bulb size
Gastric Varices
- Fundal submucosal nodular/serpiginous masses ("grape-like")
- CT/MRI: enhancing submucosal vessels on venous phase
- Efface with compression (pliable) - differentiates from neoplasm
- Portal hypertension context; absent oesophageal varices + gastric varices alone = splenic vein thrombosis (pancreatitis/pancreatic Ca)
11. ECTOPIC PANCREATIC TISSUE
- Most common site: Antrum/pylorus, greater curvature, submucosal
- Pathognomonic barium/endoscopy finding: Submucosal mass with central umbilication (represents the ductal orifice)
- CT: isoattenuating to normal pancreas, ill-defined or well-defined, duct-like structure may be visible
- MRI: same signal characteristics as normal pancreatic tissue on all sequences
- Benign; rarely complicated by pancreatitis within the rest
12. GASTRIC METASTASES
| Primary | Pattern | Key Feature |
|---|
| Melanoma | Multiple "bull's-eye" lesions | Central ulceration in submucosal mass |
| Lobular breast Ca | Linitis plastica | Diffuse wall thickening, rigid; ER/PR+ |
| Lung | Submucosal masses | Usually small, asymptomatic |
| Kaposi sarcoma | Submucosal haemorrhagic lesions | HIV context |
| Ovary (Krukenberg) | Bilateral ovarian masses + gastric primary | Signet ring cells |
13. COMPLETE DIFFERENTIAL DIAGNOSIS WITH DIFFERENTIATING FEATURES
| Entity | CT Appearance | Pathognomonic Feature | PET Avidity |
|---|
| Adenocarcinoma (intestinal) | Irregular mural thickening, fat plane loss | Shelf sign, mucosal origin | Positive |
| Diffuse Ca / Linitis plastica | Rigid non-distensible stomach | Leather bottle, no areae gastricae | Negative/low |
| MALToma | Thickened folds, fat plane preserved | Crosses pylorus, H. pylori+ | Variable (often -) |
| DLBCL | Bulky polypoid/infiltrating | Preserved fat plane, homogeneous | Positive |
| GIST | Exophytic submucosal, central necrosis | NO lymph nodes, CD117+, pseudocyst | Low/variable |
| Lipoma | Fat density (-80 to -120 HU) | Fat density + thin capsule (pathognomonic) | Negative |
| Leiomyoma | Intramural, homogeneous, GEJ | CD117-, no exophytic, calcification | Negative |
| Carcinoid/NET | Hypervascular submucosal nodules | Ga-68 DOTATATE positive | Negative (G1/2) |
| Glomus tumour | Hypervascular antral submucosal | Intense arterial enhancement (= aorta) | Variable |
| Paraganglioma | Hypervascular, extra-adrenal | Salt-and-pepper T2 MRI, DOTATATE+ | Variable |
| Schwannoma | Homogeneous, peripheral nodal cuff | S100+, CD117-, peripheral nodes | Negative |
| Ménétrier's | Massive pliable folds, antral sparing | Pliable (not rigid), protein-losing | Negative |
| ZES | Thickened folds + excess secretions | Multiple distal PUD, pancreatic mass | DOTATATE+ |
| Ectopic pancreas | Antral submucosal mass | Central umbilication (ductal orifice) | Negative |
| Gastric varices | Fundal serpiginous submucosal | Venous enhancement, pliable | Negative |
| Melanoma mets | Multiple submucosal masses | Bull's-eye (central ulceration) | Variable |
| Breast lobular mets | Linitis plastica | History, ER/PR+, bilateral ovary | Negative/low |
| Eosinophilic gastritis | Antral rigidity, wall thickening | Peripheral eosinophilia, atopic | Negative |
| Amyloidosis | Diffuse rigidity | Congo red biopsy | Negative |
| Corrosive gastritis | Deformed contracted stomach | History of ingestion | Negative |
14. QUICK REFERENCE: PATHOGNOMONIC IMAGING SIGNS
| Sign | Diagnosis |
|---|
| Leather bottle / non-distensible stomach | Linitis plastica (diffuse Ca, breast lobular mets) |
| Preserved fat plane + bulky nodes | Lymphoma favoured over carcinoma |
| Central umbilication in antral submucosal mass | Ectopic pancreatic tissue |
| Bull's-eye lesion (submucosal + central ulcer) | Melanoma mets (also GIST) |
| Fat density (-HU) with thin capsule | Gastric lipoma |
| Massive pliable folds, antral sparing | Ménétrier's disease |
| Exophytic mass, no lymph nodes | GIST |
| Intense arterial enhancement (= aorta) | Glomus tumour |
| Salt and pepper T2 MRI | Paraganglioma |
| Outer hypodense stripe preserved on CT | EGC (T1 confined) |
| Hampton's line | Benign peptic ulcer |
| Carman meniscus sign | Malignant gastric ulcer (en face) |
| Multiple hypervascular submucosal nodules | Carcinoid/NET Type 1 or 2 |
| Lymphoma crossing pylorus | Gastric lymphoma (carcinoma rarely does this) |
| Pseudo-progression/cystic change on imatinib | GIST response (use Choi, not RECIST) |
Sourced from: Grainger & Allison's Diagnostic Radiology 6e (Chapter 20); Yamada's Textbook of Gastroenterology 7e; Sleisenger & Fordtran's GI & Liver Disease; AJCC 8th Edition TNM; Lugano Classification (Cheson et al. 2014); Japanese Gastric Cancer Association Guidelines